Immunovant (IMVT) Other Non-Current Assets (2018 - 2026)
Immunovant's Other Non-Current Assets came in at $961,000 for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 89.3% from $8.94 million a year earlier and down 87.6% from the prior quarter.
Powered by 
Analysis
Immunovant (IMVT) Other Non-Current Assets (2018 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Immunovant's Other Non-Current Assets was $7.75 million, up 1.8% from FY2025.
- Going back by fiscal year, Other Non-Current Assets was $7.62 million in FY2025.
- The fiscal Q1 2027 figure represents the lowest quarterly Other Non-Current Assets since fiscal Q4 2020.
- Year-over-year, Other Non-Current Assets increased in three of the last four quarters, with an average decline of 13.8%.
- Business Quant data shows IMVT's Other Non-Current Assets at $7.75 million (Q4 2026), $8.92 million (Q3 2026) and $8.78 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Immunovant | 6.97 Bn | 6.97 Bn | - | 961,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 961,000.00 |
| Mar 31, 2026 | 7.75 Mn |
| Dec 31, 2025 | 8.92 Mn |
| Sep 30, 2025 | 8.78 Mn |
| Jun 30, 2025 | 8.94 Mn |
| Mar 31, 2025 | 7.62 Mn |
| Dec 31, 2024 | 7.62 Mn |
| Sep 30, 2024 | 7.62 Mn |
| Mar 31, 2020 | 246,000.00 |
| Mar 31, 2019 | 1.20 Mn |
| Dec 31, 2018 | 80,000.00 |
API Access
Immunovant Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();